Virdev Intermediates Private Limited, a active private limited company, was established on 01 February 1994 in Surat, Gujarat, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230GJ1994PTC021189. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹8.00 Cr and a paid-up capital of ₹5.41 Cr.
It upholds a compliant status. Employing 313 professional, Its leadership includes Kaushik Bhagwandas Jariwala (Director), Narendra Bhagwandas Jariwala (Director), Sanjay Amritlal Solanki (Director). Past directors included Pinky Monish Shah, Dharmesh Mahendra Shah, Dheer Dharmesh Shah. It holds no open charges and ₹92.47 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at S No 33/1-A Plot No-1,Khatodara B/H Sub Jail, Surat, Surat, Gujarat, 395002.
U24230GJ1994PTC021189
021189
01 February 1994
₹8.00 Cr
₹5.41 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Virdev Intermediates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kaushik Bhagwandas Jariwala | Director | 12 Nov 2000 | Current |
| Narendra Bhagwandas Jariwala | Director | 01 Feb 1994 | Current |
| Sanjay Amritlal Solanki | Director | 12 Nov 2000 | Current |
| Viralkumar Narendrabhai Jariwala | Director | 12 Nov 2000 | Current |
| Dheer Dharmesh Shah | Director | 01 Mar 2024 | Current |
| Raheel Dharmesh Shah | Director | 27 Jul 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 27 Jul 2018 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Virdev Intermediates Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 128.63% increase. The company also saw a substantial improvement in profitability, with a 408.67% increase in profit. The company's net worth Soared by an impressive increase of 35.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Virdev Intermediates had a promoter holding of 98.52% and a public holding of 1.49%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹924,700,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2015 | Kotak Mahindra Bank Limited | ₹4.90 Cr | Satisfied |
| 31 Jul 2014 | Kotak Mahindra Bank Limited | ₹18.19 Cr | Satisfied |
| 18 Jul 2014 | Ing Vysya Bank Limited | ₹16.06 Cr | Satisfied |
| 30 Jul 2013 | Central Bank Of India | ₹1.90 Cr | Satisfied |
| 23 Mar 2007 | Central Bank Of India | ₹12.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Virdev Intermediates has a workforce of 313 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Virdev Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Virdev Intermediates's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Virdev Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Virdev Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
Dheer Dharmesh Shah was appointed as a Director was appointed as a Director on 01 Mar 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
A charge registered on 27 Mar 2015 via Charge ID 10569075 with Kotak Mahindra Bank Limited was fully satisfied on 14 Sep 2022. was recorded as a recent event.
A charge registered on 31 Jul 2014 via Charge ID 10515182 with Kotak Mahindra Bank Limited was fully satisfied on 14 Sep 2022. was recorded as a recent event.
The activity A charge registered on 18 Jul 2014 via Charge ID 10516190 with Ing Vysya Bank Limited was fully satisfied on 14 Sep 2022. was completed.
When you have prostate cancer but don't want to deal with nausea from meds, try BDENZA oral solution. It's gentle on the stomach, sugar-free, and tastes good. Plus, it's only one small serving instead of lots of pills. Doctors can adjust the dose for each patient and it's affordable. BDR Pharma is changing the game with this patient-friendly solution..
The product will be available in 100 mg capsules and is the first line of treatment for the aforementioned fungal infections BDR Pharmaceutical has launched first-of-its kind generic drug, Zisavel cap.
The injection will be used for acute bacterial skin infections BDR Pharmaceuticals International has announced the launch of Dalbonova Injection. A revolutionary medication for the treatment of acute.
The CIN of Virdev Intermediates Private Limited is U24230GJ1994PTC021189.
Virdev Intermediates Private Limited is headquartered at S No 33/1-A Plot No-1,Khatodara B/H Sub Jail, Surat, Surat, Gujarat, 395002.
Virdev Intermediates Private Limited was incorporated on 01 February 1994.
The current directors of Virdev Intermediates Private Limited are
The primary industry of Virdev Intermediates Private Limited is Manufacturing.
Virdev Intermediates Private Limited is unlisted.
The authorized capital of Virdev Intermediates Private Limited is ₹8.00 Cr, and the paid-up capital is ₹5.41 Cr.
The compliance status of Virdev Intermediates Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX